Angus Stewart

Can digital tools help cell and gene therapy evolve?

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world

In 2014, the Ice Bucket Challenge raised millions; eight years on, we have an FDA-approved therapy

An inside view on the San Diego company working to bring drug delivering contact lenses to market.

Clinical trials suffer from heavy dropout rates. Perhaps the answer is a little care and attention.

The war in Ukraine has massively impacted clinical trials. We spoke to one man tracking the disruption.

Boston bioscientists have found an unlikely ally in anthrax toxins, which could form the basis for a new kind of painkiller.

How work on sharks could provide a highly effective weapon against new COVID variants

A drug development journey with origins in the 1950s has finally reached its successful conclusion: a new treatment for lupus

A Korean team have conducted a study on a peptide that could help to produce medicines capable of crossing cell membranes and interfering with PPIs